Superselective intra-arterial cerebral infusion of Bevacizumab or Cetuximab in newly diagnosed or recurrent glioblastoma: a single-center experience from 70 patients and 139 procedures

Superselective Intra-arterial Cerebral Infusion of Bevacizumab or Cetuximab in Newly Diagnosed or Recurrent Glioblastoma: A Single-center Experience from 70 Patients and 139 Procedures